Category: Support
The Long Road to Diagnosis: Why Getting Crohn’s Answers Takes So Long
Many Crohn’s patients see multiple doctors before getting diagnosed, facing dismissal and misdiagnosis along the way. Understanding why this happens and how to advocate for yourself can help you navigate the healthcare system more effectively and find the answers you deserve.
Breakthrough Stem Cell Therapy Shows Promise for Perianal Fistulas
The STOMP2 clinical trial shows promising results for AU-101, a stem cell therapy using patients’ own cells to heal Crohn’s perianal fistulas. This breakthrough represents a fundamental shift from managing symptoms to promoting lasting tissue repair and healing.
Better IBD Treatments on the Horizon: What Growth Means for Patients
Market analysis shows unprecedented growth in IBD research and treatment development, with new biologics, personalized medicine, and digital health platforms on the horizon. Here’s what this expansion means for patients and families managing Crohn’s disease and ulcerative colitis.
New UC Research Tackles Bowel Urgency – The Symptom That Controls Your Life
New clinical trial data shows promising improvements in bowel urgency for ulcerative colitis patients, addressing the symptom that often controls daily life more than any other UC symptom.
New UC Treatment Shows Promise in Just 3 Days
New clinical trial data shows OMVOH, an FDA-approved UC treatment, can start improving symptoms in just three days while maintaining benefits for a full year. This rapid-acting approach could change how we experience UC treatment, offering hope for faster relief and long-term stability.
Could This Overlooked Gut Bacteria Be a Game-Changer for IBD?
New research identifies Ruminococcus torques, a gut bacterium that strengthens the intestinal barrier and may offer new hope for IBD management. This discovery could lead to more targeted, microbiome-based therapies for inflammatory bowel disease.
Tremfya Breakthrough: First At-Home UC Treatment Changes Everything
The European Commission has approved Tremfya as the first IL-23 inhibitor that can be self-administered at home for UC treatment. This groundbreaking approval could transform how patients manage moderate to severe ulcerative colitis by eliminating the need for hospital infusions.
The Mediterranean Diet for UC: Why This Matters for Your Journey
New research suggests the Mediterranean-Style Diet could help people with ulcerative colitis by focusing on anti-inflammatory foods and flexible eating patterns. This approach shifts from restriction to nourishment, offering hope for better symptom management.
Early Crohn’s Treatment: Game-Changer for Better Outcomes
New Cambridge research shows that treating Crohn’s disease aggressively from diagnosis leads to fewer flares, hospitalizations, and better quality of life over five years. This approach could transform IBD care by preventing intestinal damage rather than just managing symptoms.
Community Research Centers: A New Hope for IBD Clinical Trials
Community research centers are bringing clinical trials closer to home, potentially revolutionizing access to cutting-edge IBD treatments. This shift could eliminate geographic barriers and create more inclusive research that better reflects real-world patient experiences.
